Idiopathic thrombocytopenic purpura: treatments, associated drugs and conditions

Summary:

Idiopathic thrombocytopenic purpura: bleeding disorder in which the immune system destroys platelets, which are necessary for normal blood clotting.

We study 16,193 people who have Idiopathic thrombocytopenic purpura. The information that eHealthMe analyzes includes:

- COVID vaccines that are associated with Idiopathic thrombocytopenic purpura
- Medications that treat Idiopathic thrombocytopenic purpura and their effectiveness
- 1,307 drugs that are associated with Idiopathic thrombocytopenic purpura
- 801 conditions that are associated with Idiopathic thrombocytopenic purpura

With medical big data and AI algorithms, eHealthMe enables everyone to run phase IV clinical trial to detect adverse drug outcomes and monitor effectiveness. Our original studies have been referenced on 600+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Most recently, phase IV clinial trails for COVID 19 vaccines have been added, check here.


Number of reports submitted per year:

Idiopathic thrombocytopenic purpura: 16,193 reports.

COVID vaccines that are associated with Idiopathic thrombocytopenic purpura:

Idiopathic thrombocytopenic purpura treatments and how effective are they?

Common drugs associated with Idiopathic thrombocytopenic purpura:

Common conditions associated with Idiopathic thrombocytopenic purpura:

Browse all Idiopathic thrombocytopenic purpura symptoms:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Do you take any medication?

- You can start a phase IV clinical trial to monitor drug safety and effectiveness.

Who is eHealthMe?

With medical big data and proven AI algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 600+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

How we gather our data?

Healthcare data is obtained from a number of sources including the Food and Drug Administration (FDA). This information is aggregated and used to produce personalized reports that patients can reference. Browse all conditions on eHealthMe.

Recent studies on eHealthMe: